Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer | NEJM

The newest entry into the metastatic hormone sensitive prostate cancer space….for those who were going to get docatexel (high volume disease), seems reasonable to add darolutamide now.

Read the full article here

Related Articles